ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted December 26, 2013

Weight Loss Supplement Recalled

On December 23, 2013, Deseo Rebajar Inc. issued a voluntary recall of one lot of Burn 7 Capsules because they were found to contain sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Recalled Burn 7 Capsules were sold directly to customers in Deseo Rebajar offices and through the company's website, www.deseorebajar.com. They are packaged in 30-count plastic bottles labeled with Lot #MFD: 07.18.2013 and Exp: 07.17.2015.

(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See Related Warnings:

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

Weight Loss Supplement Recalled Due To Undeclared Drug

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

To read more about this recall, use the link below.